chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 29.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acoustic stimulation tests abnormal, Blood test normal, Condition aggravated, Deafness unilateral, Dizziness
Clinical narrative: vertigo attack; migraine; constant headache; a constant dizziness that worsens with sounds, lights and especially motion; a constant dizziness that worsens with sounds, lights and especially motion; a constant dizziness that worsens with sounds, lights and especially motion; dizzy/light headed/a constant dizziness that worsens with sounds, lights and especially motion; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 29 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 08Feb2022 16:45 (Lot number: FE3594) at the age of 29 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Epilepsy" (unspecified if ongoing); "COVID 19", start date: Sep2021 (unspecified if ongoing). Concomitant medication(s) included: DILANTIN [PHENYTOIN]. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE; lot number:FE3594; administration time: 10:30AM; anatomical location: Left arm), administration date: 18Jan2022, when the patient was 29 years old, for COVID-19 immunization, reaction(s): "lights and sounds mildly affected me", "lights and sounds mildly affected me". The following information was reported: DIZZINESS (disability) with onset 10Feb2022 22:30, outcome "not recovered", described as "dizzy/light headed/a constant dizziness that worsens with sounds, lights and especially motion"; VERTIGO (disability) with onset 15Feb2022, outcome "not recovered", described as "vertigo attack"; MIGRAINE (disability) with onset 15Feb2022, outcome "not recovered", described as "migraine"; HEADACHE (disability) with onset 15Feb2022, outcome "not recovered", described as "constant headache"; PHOTOSENSITIVITY REACTION (disability), HYPERACUSIS (disability), MOTION SICKNESS (disability) all with onset 10Feb2022 22:30, outcome "not recovered" and all described as "a constant dizziness that worsens with sounds, lights and especially motion". The events "dizzy/light headed/a constant dizziness that worsens with sounds, lights and especially motion", "vertigo attack", "migraine", "constant headache", "a constant dizziness that worsens with sounds, lights and especially motion", "a constant dizziness that worsens with sounds, lights and especially motion" and "a constant dizziness that worsens with sounds, lights and especially motion" were evaluated at the physician office visit. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (Sep2021) positive. Therapeutic measures were taken as a result of dizziness, vertigo, migraine, headache, photosensitivity reaction, hyperacusis, motion sickness which includes migraine medication and steroids.
Age: 29.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dizziness postural, Drug level decreased, Ear discomfort, Headache, Hyperacusis
Clinical narrative: vertigo attack; migraine; constant headache; a constant dizziness that worsens with sounds, lights and especially motion; a constant dizziness that worsens with sounds, lights and especially motion; a constant dizziness that worsens with sounds, lights and especially motion; dizzy/light headed/a constant dizziness that worsens with sounds, lights and especially motion; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 29 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 08Feb2022 16:45 (Lot number: FE3594) at the age of 29 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Epilepsy" (unspecified if ongoing); "COVID 19", start date: Sep2021 (unspecified if ongoing). Concomitant medication(s) included: DILANTIN [PHENYTOIN]. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE; lot number:FE3594; administration time: 10:30AM; anatomical location: Left arm), administration date: 18Jan2022, when the patient was 29 years old, for COVID-19 immunization, reaction(s): "lights and sounds mildly affected me", "lights and sounds mildly affected me". The following information was reported: DIZZINESS (disability) with onset 10Feb2022 22:30, outcome "not recovered", described as "dizzy/light headed/a constant dizziness that worsens with sounds, lights and especially motion"; VERTIGO (disability) with onset 15Feb2022, outcome "not recovered", described as "vertigo attack"; MIGRAINE (disability) with onset 15Feb2022, outcome "not recovered", described as "migraine"; HEADACHE (disability) with onset 15Feb2022, outcome "not recovered", described as "constant headache"; PHOTOSENSITIVITY REACTION (disability), HYPERACUSIS (disability), MOTION SICKNESS (disability) all with onset 10Feb2022 22:30, outcome "not recovered" and all described as "a constant dizziness that worsens with sounds, lights and especially motion". The events "dizzy/light headed/a constant dizziness that worsens with sounds, lights and especially motion", "vertigo attack", "migraine", "constant headache", "a constant dizziness that worsens with sounds, lights and especially motion", "a constant dizziness that worsens with sounds, lights and especially motion" and "a constant dizziness that worsens with sounds, lights and especially motion" were evaluated at the physician office visit. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (Sep2021) positive. Therapeutic measures were taken as a result of dizziness, vertigo, migraine, headache, photosensitivity reaction, hyperacusis, motion sickness which includes migraine medication and steroids.
Age: 29.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Impaired driving ability, Impaired work ability, Laboratory test normal, Loss of personal independence in daily activities, Migraine
Clinical narrative: vertigo attack; migraine; constant headache; a constant dizziness that worsens with sounds, lights and especially motion; a constant dizziness that worsens with sounds, lights and especially motion; a constant dizziness that worsens with sounds, lights and especially motion; dizzy/light headed/a constant dizziness that worsens with sounds, lights and especially motion; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 29 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 08Feb2022 16:45 (Lot number: FE3594) at the age of 29 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Epilepsy" (unspecified if ongoing); "COVID 19", start date: Sep2021 (unspecified if ongoing). Concomitant medication(s) included: DILANTIN [PHENYTOIN]. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE; lot number:FE3594; administration time: 10:30AM; anatomical location: Left arm), administration date: 18Jan2022, when the patient was 29 years old, for COVID-19 immunization, reaction(s): "lights and sounds mildly affected me", "lights and sounds mildly affected me". The following information was reported: DIZZINESS (disability) with onset 10Feb2022 22:30, outcome "not recovered", described as "dizzy/light headed/a constant dizziness that worsens with sounds, lights and especially motion"; VERTIGO (disability) with onset 15Feb2022, outcome "not recovered", described as "vertigo attack"; MIGRAINE (disability) with onset 15Feb2022, outcome "not recovered", described as "migraine"; HEADACHE (disability) with onset 15Feb2022, outcome "not recovered", described as "constant headache"; PHOTOSENSITIVITY REACTION (disability), HYPERACUSIS (disability), MOTION SICKNESS (disability) all with onset 10Feb2022 22:30, outcome "not recovered" and all described as "a constant dizziness that worsens with sounds, lights and especially motion". The events "dizzy/light headed/a constant dizziness that worsens with sounds, lights and especially motion", "vertigo attack", "migraine", "constant headache", "a constant dizziness that worsens with sounds, lights and especially motion", "a constant dizziness that worsens with sounds, lights and especially motion" and "a constant dizziness that worsens with sounds, lights and especially motion" were evaluated at the physician office visit. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (Sep2021) positive. Therapeutic measures were taken as a result of dizziness, vertigo, migraine, headache, photosensitivity reaction, hyperacusis, motion sickness which includes migraine medication and steroids.
Age: 29.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Nausea, Ophthalmological examination normal, Photophobia, Vertigo, Vertigo positional
Clinical narrative: vertigo attack; migraine; constant headache; a constant dizziness that worsens with sounds, lights and especially motion; a constant dizziness that worsens with sounds, lights and especially motion; a constant dizziness that worsens with sounds, lights and especially motion; dizzy/light headed/a constant dizziness that worsens with sounds, lights and especially motion; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 29 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 08Feb2022 16:45 (Lot number: FE3594) at the age of 29 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Epilepsy" (unspecified if ongoing); "COVID 19", start date: Sep2021 (unspecified if ongoing). Concomitant medication(s) included: DILANTIN [PHENYTOIN]. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE; lot number:FE3594; administration time: 10:30AM; anatomical location: Left arm), administration date: 18Jan2022, when the patient was 29 years old, for COVID-19 immunization, reaction(s): "lights and sounds mildly affected me", "lights and sounds mildly affected me". The following information was reported: DIZZINESS (disability) with onset 10Feb2022 22:30, outcome "not recovered", described as "dizzy/light headed/a constant dizziness that worsens with sounds, lights and especially motion"; VERTIGO (disability) with onset 15Feb2022, outcome "not recovered", described as "vertigo attack"; MIGRAINE (disability) with onset 15Feb2022, outcome "not recovered", described as "migraine"; HEADACHE (disability) with onset 15Feb2022, outcome "not recovered", described as "constant headache"; PHOTOSENSITIVITY REACTION (disability), HYPERACUSIS (disability), MOTION SICKNESS (disability) all with onset 10Feb2022 22:30, outcome "not recovered" and all described as "a constant dizziness that worsens with sounds, lights and especially motion". The events "dizzy/light headed/a constant dizziness that worsens with sounds, lights and especially motion", "vertigo attack", "migraine", "constant headache", "a constant dizziness that worsens with sounds, lights and especially motion", "a constant dizziness that worsens with sounds, lights and especially motion" and "a constant dizziness that worsens with sounds, lights and especially motion" were evaluated at the physician office visit. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (Sep2021) positive. Therapeutic measures were taken as a result of dizziness, vertigo, migraine, headache, photosensitivity reaction, hyperacusis, motion sickness which includes migraine medication and steroids.
Age: 29.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: X-ray abnormal
Clinical narrative: vertigo attack; migraine; constant headache; a constant dizziness that worsens with sounds, lights and especially motion; a constant dizziness that worsens with sounds, lights and especially motion; a constant dizziness that worsens with sounds, lights and especially motion; dizzy/light headed/a constant dizziness that worsens with sounds, lights and especially motion; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 29 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 08Feb2022 16:45 (Lot number: FE3594) at the age of 29 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Epilepsy" (unspecified if ongoing); "COVID 19", start date: Sep2021 (unspecified if ongoing). Concomitant medication(s) included: DILANTIN [PHENYTOIN]. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE; lot number:FE3594; administration time: 10:30AM; anatomical location: Left arm), administration date: 18Jan2022, when the patient was 29 years old, for COVID-19 immunization, reaction(s): "lights and sounds mildly affected me", "lights and sounds mildly affected me". The following information was reported: DIZZINESS (disability) with onset 10Feb2022 22:30, outcome "not recovered", described as "dizzy/light headed/a constant dizziness that worsens with sounds, lights and especially motion"; VERTIGO (disability) with onset 15Feb2022, outcome "not recovered", described as "vertigo attack"; MIGRAINE (disability) with onset 15Feb2022, outcome "not recovered", described as "migraine"; HEADACHE (disability) with onset 15Feb2022, outcome "not recovered", described as "constant headache"; PHOTOSENSITIVITY REACTION (disability), HYPERACUSIS (disability), MOTION SICKNESS (disability) all with onset 10Feb2022 22:30, outcome "not recovered" and all described as "a constant dizziness that worsens with sounds, lights and especially motion". The events "dizzy/light headed/a constant dizziness that worsens with sounds, lights and especially motion", "vertigo attack", "migraine", "constant headache", "a constant dizziness that worsens with sounds, lights and especially motion", "a constant dizziness that worsens with sounds, lights and especially motion" and "a constant dizziness that worsens with sounds, lights and especially motion" were evaluated at the physician office visit. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (Sep2021) positive. Therapeutic measures were taken as a result of dizziness, vertigo, migraine, headache, photosensitivity reaction, hyperacusis, motion sickness which includes migraine medication and steroids.
Age: 29.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dizziness, Headache, Hyperacusis, Migraine, Motion sickness
Clinical narrative: vertigo attack; migraine; constant headache; a constant dizziness that worsens with sounds, lights and especially motion; a constant dizziness that worsens with sounds, lights and especially motion; a constant dizziness that worsens with sounds, lights and especially motion; dizzy/light headed/a constant dizziness that worsens with sounds, lights and especially motion; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 29 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 08Feb2022 16:45 (Lot number: FE3594) at the age of 29 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Epilepsy" (unspecified if ongoing); "COVID 19", start date: Sep2021 (unspecified if ongoing). Concomitant medication(s) included: DILANTIN [PHENYTOIN]. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE; lot number:FE3594; administration time: 10:30AM; anatomical location: Left arm), administration date: 18Jan2022, when the patient was 29 years old, for COVID-19 immunization, reaction(s): "lights and sounds mildly affected me", "lights and sounds mildly affected me". The following information was reported: DIZZINESS (disability) with onset 10Feb2022 22:30, outcome "not recovered", described as "dizzy/light headed/a constant dizziness that worsens with sounds, lights and especially motion"; VERTIGO (disability) with onset 15Feb2022, outcome "not recovered", described as "vertigo attack"; MIGRAINE (disability) with onset 15Feb2022, outcome "not recovered", described as "migraine"; HEADACHE (disability) with onset 15Feb2022, outcome "not recovered", described as "constant headache"; PHOTOSENSITIVITY REACTION (disability), HYPERACUSIS (disability), MOTION SICKNESS (disability) all with onset 10Feb2022 22:30, outcome "not recovered" and all described as "a constant dizziness that worsens with sounds, lights and especially motion". The events "dizzy/light headed/a constant dizziness that worsens with sounds, lights and especially motion", "vertigo attack", "migraine", "constant headache", "a constant dizziness that worsens with sounds, lights and especially motion", "a constant dizziness that worsens with sounds, lights and especially motion" and "a constant dizziness that worsens with sounds, lights and especially motion" were evaluated at the physician office visit. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (Sep2021) positive. Therapeutic measures were taken as a result of dizziness, vertigo, migraine, headache, photosensitivity reaction, hyperacusis, motion sickness which includes migraine medication and steroids.
Age: 29.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Photosensitivity reaction, SARS-CoV-2 test, Vertigo
Clinical narrative: vertigo attack; migraine; constant headache; a constant dizziness that worsens with sounds, lights and especially motion; a constant dizziness that worsens with sounds, lights and especially motion; a constant dizziness that worsens with sounds, lights and especially motion; dizzy/light headed/a constant dizziness that worsens with sounds, lights and especially motion; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 29 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 08Feb2022 16:45 (Lot number: FE3594) at the age of 29 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Epilepsy" (unspecified if ongoing); "COVID 19", start date: Sep2021 (unspecified if ongoing). Concomitant medication(s) included: DILANTIN [PHENYTOIN]. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE; lot number:FE3594; administration time: 10:30AM; anatomical location: Left arm), administration date: 18Jan2022, when the patient was 29 years old, for COVID-19 immunization, reaction(s): "lights and sounds mildly affected me", "lights and sounds mildly affected me". The following information was reported: DIZZINESS (disability) with onset 10Feb2022 22:30, outcome "not recovered", described as "dizzy/light headed/a constant dizziness that worsens with sounds, lights and especially motion"; VERTIGO (disability) with onset 15Feb2022, outcome "not recovered", described as "vertigo attack"; MIGRAINE (disability) with onset 15Feb2022, outcome "not recovered", described as "migraine"; HEADACHE (disability) with onset 15Feb2022, outcome "not recovered", described as "constant headache"; PHOTOSENSITIVITY REACTION (disability), HYPERACUSIS (disability), MOTION SICKNESS (disability) all with onset 10Feb2022 22:30, outcome "not recovered" and all described as "a constant dizziness that worsens with sounds, lights and especially motion". The events "dizzy/light headed/a constant dizziness that worsens with sounds, lights and especially motion", "vertigo attack", "migraine", "constant headache", "a constant dizziness that worsens with sounds, lights and especially motion", "a constant dizziness that worsens with sounds, lights and especially motion" and "a constant dizziness that worsens with sounds, lights and especially motion" were evaluated at the physician office visit. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (Sep2021) positive. Therapeutic measures were taken as a result of dizziness, vertigo, migraine, headache, photosensitivity reaction, hyperacusis, motion sickness which includes migraine medication and steroids.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Headache, Injection site erythema, Injection site pruritus, Injection site rash
Clinical narrative: Site: Itching at Injection Site-Medium, Site: Redness at Injection Site-Medium, Systemic: Headache-Mild
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Oropharyngeal pain
Clinical narrative: Site: Itching at Injection Site-Medium, Site: Redness at Injection Site-Medium, Systemic: Headache-Mild
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Injection site erythema, Injection site pruritus
Clinical narrative: Site: Itching at Injection Site-Medium, Site: Redness at Injection Site-Medium, Systemic: Headache-Mild
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Blood test normal, Chest X-ray normal, Electrocardiogram normal, Impaired work ability, Malaise
Clinical narrative: This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administered in arm, administration date 15Mar2022 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), administration date: 11Feb2022, for COVID-19 Immunization, reaction(s): "I did not feel any side effects". The following information was reported: VOMITING (hospitalization) with onset 15Mar2022, outcome "unknown", described as "puked"; HYPERTENSION (hospitalization) with onset Mar2022, outcome "unknown", described as "blood pressure went through the roof". The patient was hospitalized for vomiting, hypertension (start date: 17Mar2022). The patient underwent the following laboratory tests and procedures: blood pressure measurement: (Mar2022) went through the roof.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Neck pain, Pain in extremity, Skull X-ray, Vomiting
Clinical narrative: This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administered in arm, administration date 15Mar2022 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), administration date: 11Feb2022, for COVID-19 Immunization, reaction(s): "I did not feel any side effects". The following information was reported: VOMITING (hospitalization) with onset 15Mar2022, outcome "unknown", described as "puked"; HYPERTENSION (hospitalization) with onset Mar2022, outcome "unknown", described as "blood pressure went through the roof". The patient was hospitalized for vomiting, hypertension (start date: 17Mar2022). The patient underwent the following laboratory tests and procedures: blood pressure measurement: (Mar2022) went through the roof.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Blood pressure measurement, Hypertension, Vomiting
Clinical narrative: This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administered in arm, administration date 15Mar2022 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), administration date: 11Feb2022, for COVID-19 Immunization, reaction(s): "I did not feel any side effects". The following information was reported: VOMITING (hospitalization) with onset 15Mar2022, outcome "unknown", described as "puked"; HYPERTENSION (hospitalization) with onset Mar2022, outcome "unknown", described as "blood pressure went through the roof". The patient was hospitalized for vomiting, hypertension (start date: 17Mar2022). The patient underwent the following laboratory tests and procedures: blood pressure measurement: (Mar2022) went through the roof.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 33.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Rash, Urticaria
Clinical narrative: Little bit of tightening in my throat.; Can't sleep; Hives all over my body.; it itches, so its worse right now; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 33 year-old male patient received bnt162b2 (BNT162B2), administered in arm, administration date 19Mar2022 (Lot number: PK9895) at the age of 33 years as dose 3 (booster), single for covid-19 immunisation. The patient had no relevant medical history. The patient took concomitant medications. Vaccination history included: Bnt162b2 (Dose: 1), for COVID-19 immunization; Bnt162b2 (dose: 2), for COVID-19 immunization. The following information was reported: THROAT TIGHTNESS (non-serious) with onset 2022, outcome "unknown", described as "Little bit of tightening in my throat."; URTICARIA (non-serious) with onset 2022, outcome "unknown", described as "Hives all over my body."; INSOMNIA (non-serious) with onset 2022, outcome "unknown", described as "Can't sleep"; PRURITUS (non-serious) with onset 2022, outcome "unknown", described as "it itches, so its worse right now". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of throat tightness, urticaria, insomnia, pruritus.  Additional information: The patient got Covid booster about a week and half ago and had like hives all over body and struggling to had a little bit of tightening in throat as well. Consumer stated, he frequently an allergy medication like a seasonal allergy medication. Consumer stated, It got better throughout the day and he was calling right now because he could not sleep it itched, so its worsed right now  Follow-up attempts are completed. No further information is expected.
Age: 33.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Insomnia, Pruritus, Throat tightness, Tuberculin test, Urticaria
Clinical narrative: Little bit of tightening in my throat.; Can't sleep; Hives all over my body.; it itches, so its worse right now; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 33 year-old male patient received bnt162b2 (BNT162B2), administered in arm, administration date 19Mar2022 (Lot number: PK9895) at the age of 33 years as dose 3 (booster), single for covid-19 immunisation. The patient had no relevant medical history. The patient took concomitant medications. Vaccination history included: Bnt162b2 (Dose: 1), for COVID-19 immunization; Bnt162b2 (dose: 2), for COVID-19 immunization. The following information was reported: THROAT TIGHTNESS (non-serious) with onset 2022, outcome "unknown", described as "Little bit of tightening in my throat."; URTICARIA (non-serious) with onset 2022, outcome "unknown", described as "Hives all over my body."; INSOMNIA (non-serious) with onset 2022, outcome "unknown", described as "Can't sleep"; PRURITUS (non-serious) with onset 2022, outcome "unknown", described as "it itches, so its worse right now". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of throat tightness, urticaria, insomnia, pruritus.  Additional information: The patient got Covid booster about a week and half ago and had like hives all over body and struggling to had a little bit of tightening in throat as well. Consumer stated, he frequently an allergy medication like a seasonal allergy medication. Consumer stated, It got better throughout the day and he was calling right now because he could not sleep it itched, so its worsed right now  Follow-up attempts are completed. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Illness, Limb discomfort, Pain in extremity, Pyrexia
Clinical narrative: Arm soreness; Felt sick; Fever; couldn't even pick up arm; Felt like she had Covid; Felt like she had Covid; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  AA 61 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 23Dec2020 (Lot number: EK5730) at the age of 60 years as dose 1, single, administered in arm left, administration date 13Jan2021 (Lot number: EK5730) as dose 2, single and administered in arm left, administration date 15Oct2021 (Lot number: FE3590) as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "COVID-19", start date: 01Dec2019 (unspecified if ongoing), notes: diagnosed with Covid on 01Dec2019, prior to receiving any dose of the Pfizer Covid Vaccine. There were no concomitant medications. Vaccination history included: Measles (caller has ever gotten were when was a young kid for measles, mumps and rubella); Mumps (caller has ever gotten were when was a young kid for measles, mumps and rubella); Rubella (caller has ever gotten were when was a young kid for measles, mumps and rubella). The following information was reported: VACCINATION FAILURE (medically significant), SUSPECTED COVID-19 (medically significant) all with onset 2021, outcome "unknown" and all described as "Felt like she had Covid"; PAIN IN EXTREMITY (non-serious), outcome "recovered", described as "Arm soreness"; MALAISE (non-serious), outcome "unknown", described as "Felt sick"; PYREXIA (non-serious), outcome "unknown", described as "Fever"; JOINT RANGE OF MOTION DECREASED (non-serious), outcome "unknown", described as "couldn't even pick up arm".  Additional Information: Patient states that after taking all the doses she experienced arm soreness, felt sick, had a fever and felt like she had Covid. She is 61-year-old and received the adult formulation, purple cap. She gave no other information on additional side effects. Patient states that the Arm was so sore that she  couldn't pick up arm after receiving every dose of the Adult Pfizer Covid Vaccine, first, second and booster dose. The caller go sick after every dose of the Adult Pfizer Covid Vaccine, first second and booster dose. Got sick: It was like the caller had Covid. The caller had a fever. Caller would say the arm soreness started the next day after each first, second and booster dose. The caller's arm soreness has gone away, just lasted a few days. Time the Vaccination Was Given was for first dose: afternoon about 14:00 or 14:30. She did not require a visit to Emergency Room and  Physician Office. The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. Relevant Tests was reported as none.  No follow-up attempts are possible. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Joint range of motion decreased, Malaise, Pain in extremity, Pyrexia, Suspected COVID-19
Clinical narrative: Arm soreness; Felt sick; Fever; couldn't even pick up arm; Felt like she had Covid; Felt like she had Covid; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  AA 61 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 23Dec2020 (Lot number: EK5730) at the age of 60 years as dose 1, single, administered in arm left, administration date 13Jan2021 (Lot number: EK5730) as dose 2, single and administered in arm left, administration date 15Oct2021 (Lot number: FE3590) as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "COVID-19", start date: 01Dec2019 (unspecified if ongoing), notes: diagnosed with Covid on 01Dec2019, prior to receiving any dose of the Pfizer Covid Vaccine. There were no concomitant medications. Vaccination history included: Measles (caller has ever gotten were when was a young kid for measles, mumps and rubella); Mumps (caller has ever gotten were when was a young kid for measles, mumps and rubella); Rubella (caller has ever gotten were when was a young kid for measles, mumps and rubella). The following information was reported: VACCINATION FAILURE (medically significant), SUSPECTED COVID-19 (medically significant) all with onset 2021, outcome "unknown" and all described as "Felt like she had Covid"; PAIN IN EXTREMITY (non-serious), outcome "recovered", described as "Arm soreness"; MALAISE (non-serious), outcome "unknown", described as "Felt sick"; PYREXIA (non-serious), outcome "unknown", described as "Fever"; JOINT RANGE OF MOTION DECREASED (non-serious), outcome "unknown", described as "couldn't even pick up arm".  Additional Information: Patient states that after taking all the doses she experienced arm soreness, felt sick, had a fever and felt like she had Covid. She is 61-year-old and received the adult formulation, purple cap. She gave no other information on additional side effects. Patient states that the Arm was so sore that she  couldn't pick up arm after receiving every dose of the Adult Pfizer Covid Vaccine, first, second and booster dose. The caller go sick after every dose of the Adult Pfizer Covid Vaccine, first second and booster dose. Got sick: It was like the caller had Covid. The caller had a fever. Caller would say the arm soreness started the next day after each first, second and booster dose. The caller's arm soreness has gone away, just lasted a few days. Time the Vaccination Was Given was for first dose: afternoon about 14:00 or 14:30. She did not require a visit to Emergency Room and  Physician Office. The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. Relevant Tests was reported as none.  No follow-up attempts are possible. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vaccination failure
Clinical narrative: Arm soreness; Felt sick; Fever; couldn't even pick up arm; Felt like she had Covid; Felt like she had Covid; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  AA 61 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 23Dec2020 (Lot number: EK5730) at the age of 60 years as dose 1, single, administered in arm left, administration date 13Jan2021 (Lot number: EK5730) as dose 2, single and administered in arm left, administration date 15Oct2021 (Lot number: FE3590) as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "COVID-19", start date: 01Dec2019 (unspecified if ongoing), notes: diagnosed with Covid on 01Dec2019, prior to receiving any dose of the Pfizer Covid Vaccine. There were no concomitant medications. Vaccination history included: Measles (caller has ever gotten were when was a young kid for measles, mumps and rubella); Mumps (caller has ever gotten were when was a young kid for measles, mumps and rubella); Rubella (caller has ever gotten were when was a young kid for measles, mumps and rubella). The following information was reported: VACCINATION FAILURE (medically significant), SUSPECTED COVID-19 (medically significant) all with onset 2021, outcome "unknown" and all described as "Felt like she had Covid"; PAIN IN EXTREMITY (non-serious), outcome "recovered", described as "Arm soreness"; MALAISE (non-serious), outcome "unknown", described as "Felt sick"; PYREXIA (non-serious), outcome "unknown", described as "Fever"; JOINT RANGE OF MOTION DECREASED (non-serious), outcome "unknown", described as "couldn't even pick up arm".  Additional Information: Patient states that after taking all the doses she experienced arm soreness, felt sick, had a fever and felt like she had Covid. She is 61-year-old and received the adult formulation, purple cap. She gave no other information on additional side effects. Patient states that the Arm was so sore that she  couldn't pick up arm after receiving every dose of the Adult Pfizer Covid Vaccine, first, second and booster dose. The caller go sick after every dose of the Adult Pfizer Covid Vaccine, first second and booster dose. Got sick: It was like the caller had Covid. The caller had a fever. Caller would say the arm soreness started the next day after each first, second and booster dose. The caller's arm soreness has gone away, just lasted a few days. Time the Vaccination Was Given was for first dose: afternoon about 14:00 or 14:30. She did not require a visit to Emergency Room and  Physician Office. The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. Relevant Tests was reported as none.  No follow-up attempts are possible. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Amnesia, Anxiety, Decreased appetite, Dizziness, Essential tremor
Clinical narrative: BRAIN TREMOR/FELT LIKE HER BRAIN WAS SHAKING INSIDE HER HEAD; BRAIN FOG; LOSS OF APPETITE; SEVERE ANXIETY; NOT WALKING STRAIGHT/NOT ABLE TO WALK PROPERLY/KEPT WALKING TO THE RIGHT; CAN'T FOCUS/HARD TO CONCENTRATE; DIZZINESS; PAIN AT LEFT SIDE OF NECK AT THE BASE OF SKULL; MEMORY LOSS; HARD TO WORK; This spontaneous report received from a patient concerned a 58 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and expiry: UNKNOWN) dose was not reported, administered on 03-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the patient experienced brain tremor/felt like her brain was shaking inside her head, brain fog, loss of appetite, severe anxiety, not walking straight/not able to walk properly/kept walking to the right, can't focus/hard to concentrate, dizziness, pain at left side of neck at the base of skull, memory loss, and hard to work. Laboratory data (dates unspecified) included: MRI (NR: not provided) Normal. Treatment medications (dates unspecified) included: buspirone, and alprazolam. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from not walking straight/not able to walk properly/kept walking to the right, and had not recovered from brain tremor/felt like her brain was shaking inside her head, brain fog, loss of appetite, severe anxiety, can't focus/hard to concentrate, dizziness, pain at left side of neck at the base of skull, memory loss, and hard to work. This report was non-serious.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Feeling abnormal, Gait disturbance, Magnetic resonance imaging, Night sweats, Weight decreased
Clinical narrative: BRAIN TREMOR/FELT LIKE HER BRAIN WAS SHAKING INSIDE HER HEAD; BRAIN FOG; LOSS OF APPETITE; SEVERE ANXIETY; NOT WALKING STRAIGHT/NOT ABLE TO WALK PROPERLY/KEPT WALKING TO THE RIGHT; CAN'T FOCUS/HARD TO CONCENTRATE; DIZZINESS; PAIN AT LEFT SIDE OF NECK AT THE BASE OF SKULL; MEMORY LOSS; HARD TO WORK; This spontaneous report received from a patient concerned a 58 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and expiry: UNKNOWN) dose was not reported, administered on 03-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the patient experienced brain tremor/felt like her brain was shaking inside her head, brain fog, loss of appetite, severe anxiety, not walking straight/not able to walk properly/kept walking to the right, can't focus/hard to concentrate, dizziness, pain at left side of neck at the base of skull, memory loss, and hard to work. Laboratory data (dates unspecified) included: MRI (NR: not provided) Normal. Treatment medications (dates unspecified) included: buspirone, and alprazolam. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from not walking straight/not able to walk properly/kept walking to the right, and had not recovered from brain tremor/felt like her brain was shaking inside her head, brain fog, loss of appetite, severe anxiety, can't focus/hard to concentrate, dizziness, pain at left side of neck at the base of skull, memory loss, and hard to work. This report was non-serious.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Amnesia, Anxiety, Decreased appetite, Disturbance in attention, Dizziness
Clinical narrative: BRAIN TREMOR/FELT LIKE HER BRAIN WAS SHAKING INSIDE HER HEAD; BRAIN FOG; LOSS OF APPETITE; SEVERE ANXIETY; NOT WALKING STRAIGHT/NOT ABLE TO WALK PROPERLY/KEPT WALKING TO THE RIGHT; CAN'T FOCUS/HARD TO CONCENTRATE; DIZZINESS; PAIN AT LEFT SIDE OF NECK AT THE BASE OF SKULL; MEMORY LOSS; HARD TO WORK; This spontaneous report received from a patient concerned a 58 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and expiry: UNKNOWN) dose was not reported, administered on 03-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the patient experienced brain tremor/felt like her brain was shaking inside her head, brain fog, loss of appetite, severe anxiety, not walking straight/not able to walk properly/kept walking to the right, can't focus/hard to concentrate, dizziness, pain at left side of neck at the base of skull, memory loss, and hard to work. Laboratory data (dates unspecified) included: MRI (NR: not provided) Normal. Treatment medications (dates unspecified) included: buspirone, and alprazolam. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from not walking straight/not able to walk properly/kept walking to the right, and had not recovered from brain tremor/felt like her brain was shaking inside her head, brain fog, loss of appetite, severe anxiety, can't focus/hard to concentrate, dizziness, pain at left side of neck at the base of skull, memory loss, and hard to work. This report was non-serious.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Feeling abnormal, Gait disturbance, Impaired work ability, Magnetic resonance imaging, Neck pain
Clinical narrative: BRAIN TREMOR/FELT LIKE HER BRAIN WAS SHAKING INSIDE HER HEAD; BRAIN FOG; LOSS OF APPETITE; SEVERE ANXIETY; NOT WALKING STRAIGHT/NOT ABLE TO WALK PROPERLY/KEPT WALKING TO THE RIGHT; CAN'T FOCUS/HARD TO CONCENTRATE; DIZZINESS; PAIN AT LEFT SIDE OF NECK AT THE BASE OF SKULL; MEMORY LOSS; HARD TO WORK; This spontaneous report received from a patient concerned a 58 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and expiry: UNKNOWN) dose was not reported, administered on 03-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the patient experienced brain tremor/felt like her brain was shaking inside her head, brain fog, loss of appetite, severe anxiety, not walking straight/not able to walk properly/kept walking to the right, can't focus/hard to concentrate, dizziness, pain at left side of neck at the base of skull, memory loss, and hard to work. Laboratory data (dates unspecified) included: MRI (NR: not provided) Normal. Treatment medications (dates unspecified) included: buspirone, and alprazolam. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from not walking straight/not able to walk properly/kept walking to the right, and had not recovered from brain tremor/felt like her brain was shaking inside her head, brain fog, loss of appetite, severe anxiety, can't focus/hard to concentrate, dizziness, pain at left side of neck at the base of skull, memory loss, and hard to work. This report was non-serious.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tremor
Clinical narrative: BRAIN TREMOR/FELT LIKE HER BRAIN WAS SHAKING INSIDE HER HEAD; BRAIN FOG; LOSS OF APPETITE; SEVERE ANXIETY; NOT WALKING STRAIGHT/NOT ABLE TO WALK PROPERLY/KEPT WALKING TO THE RIGHT; CAN'T FOCUS/HARD TO CONCENTRATE; DIZZINESS; PAIN AT LEFT SIDE OF NECK AT THE BASE OF SKULL; MEMORY LOSS; HARD TO WORK; This spontaneous report received from a patient concerned a 58 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and expiry: UNKNOWN) dose was not reported, administered on 03-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the patient experienced brain tremor/felt like her brain was shaking inside her head, brain fog, loss of appetite, severe anxiety, not walking straight/not able to walk properly/kept walking to the right, can't focus/hard to concentrate, dizziness, pain at left side of neck at the base of skull, memory loss, and hard to work. Laboratory data (dates unspecified) included: MRI (NR: not provided) Normal. Treatment medications (dates unspecified) included: buspirone, and alprazolam. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from not walking straight/not able to walk properly/kept walking to the right, and had not recovered from brain tremor/felt like her brain was shaking inside her head, brain fog, loss of appetite, severe anxiety, can't focus/hard to concentrate, dizziness, pain at left side of neck at the base of skull, memory loss, and hard to work. This report was non-serious.
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Magnetic resonance imaging, Tinnitus
Clinical narrative: ear ringing
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tinnitus
Clinical narrative: ear ringing
Age: 23.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anxiety, Sensation of foreign body
Clinical narrative: Several hours after the vaccine, patient started her menstrual cycle 3 days early. She has been bleeding heavily. She does not usually bleed this heavily. Patient will be following-up with her provider.
Age: 23.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Heavy menstrual bleeding, Oligomenorrhoea
Clinical narrative: Several hours after the vaccine, patient started her menstrual cycle 3 days early. She has been bleeding heavily. She does not usually bleed this heavily. Patient will be following-up with her provider.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Acupuncture, Asthenia, Hypoaesthesia, Pain, Paraesthesia
Clinical narrative: Numbness to Right leg, weakness, tingling, extreme pain
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: X-ray
Clinical narrative: Numbness to Right leg, weakness, tingling, extreme pain
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, Arthralgia, Chills, Erythema, Fatigue
Clinical narrative: Body hot,  face red hot, right after shot.  Next day chills, fever (100), fatigue, aching body. chills and body shaking,, neck lymph nodes enlarged,  could not eat,  heavy pain in lower stomach,  hot and cold and shaking.;  slept long.  Next day (today)  Joints ache, fatigue, lesser chills,  lesser lower stomach pain.  No pain at injection site. Face is flush;   fever down